Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
PARP16 is a Druggable Regulator of Ribosome MARylation and Protein Homeostasis in Ovarian Cancer Cells.
Journal: bioRxiv : the preprint server for biology
Published: April 10, 2026
Uterine organoids reveal insights into epithelial specification and plasticity in development and disease.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: January 30, 2025
RBN-2397, a PARP7 Inhibitor, Synergizes with Paclitaxel to Inhibit Proliferation and Migration of Ovarian Cancer Cells.
Journal: bioRxiv : the preprint server for biology
Published: September 04, 2024
Biological Functions and Therapeutic Potential of NAD+ Metabolism in Gynecological Cancers.
Journal: Cancers
Published: July 31, 2024
RACK1 MARylation regulates translation and stress granules in ovarian cancer cells.
Journal: The Journal of cell biology
Published: January 19, 2024
A PARP14/TARG1-Regulated RACK1 MARylation Cycle Drives Stress Granule Dynamics in Ovarian Cancer Cells.
Journal: bioRxiv : the preprint server for biology
Published: October 24, 2023
Detecting Poly (ADP-Ribose) In Vitro and in Cells Using PAR Trackers.
Journal: Methods in molecular biology (Clifton, N.J.)
Published: December 14, 2022
Two birds, one stone: Non-canonical therapeutic effects of the PARP inhibitor Talazoparib.
Journal: Cell chemical biology
Published: February 18, 2022
Development and characterization of new tools for detecting poly(ADP-ribose) in vitro and in vivo.
Journal: eLife
Published: July 24, 2021
Last Updated: 09/26/2026